The HIV Tat protein competes with the 7SK:HEXIM interaction to hijack pTEFb from 7SK snRNP and recruit it to the TAR motif on stalled viral transcripts. Here we solve structures of 7SK stemloop-1 and TAR in complex with Tat's RNA binding domain (RBD) to gain insights into this process. We find that 7SK is peppered with arginine sandwich motifs (ASM)-three classical and one with a pseudo configuration. Despite having similar RBDs, the presence of an additional arginine, R52, confers Tat the ability to remodel the pseudo configuration, required for HEXIM binding, into a classical sandwich, thus displacing HEXIM. Tat also uses R52 to remodel the TAR bulge into an ASM whose structure is identical to that of the remodeled ASM in 7SK. Together, our structures reveal a dual structural mimicry wherein viral Tat and TAR have co-opted structural motifs present in cellular HEXIM and 7SK for productive transcription of its genome.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189040PMC
http://dx.doi.org/10.1038/s41467-018-06591-6DOI Listing

Publication Analysis

Top Keywords

dual structural
8
structural mimicry
8
pseudo configuration
8
7sk
6
tar
5
hiv-1 tat
4
tat interactions
4
interactions cellular
4
cellular 7sk
4
7sk viral
4

Similar Publications

In composite structures, the precise identification and localization of damage is necessary to preserve structural integrity in applications across such fields as aeronautical, civil, and mechanical engineering. This study presents a deep learning (DL)-assisted framework for simultaneous damage localization and severity assessment in composite structures using Lamb waves (LWs). Previous studies have often focused on either damage detection or localization in composite structures.

View Article and Find Full Text PDF

Diabetes is a growing global health crisis that requires effective therapeutic strategies to optimize treatment outcomes. This study aims to address this challenge by developing and characterizing extended-release polymeric matrix tablets containing metformin hydrochloride (M-HCl), a first-line treatment for type 2 diabetes, and honokiol (HNK), a bioactive compound with potential therapeutic benefits. The objective is to enhance glycemic control and overall therapeutic outcomes through an innovative dual-drug delivery system.

View Article and Find Full Text PDF

In this study, dual-root soybean ( L. Merr.) plants, with one side nodulated and the other nonnodulated, were used as experimental materials.

View Article and Find Full Text PDF

A D-Band Dual-Polarized High-Gain LTCC-Based Reflectarray Antenna Using SIW Magnetoelectric-Dipole Elements.

Micromachines (Basel)

December 2024

State Key Laboratory of Millimeter-Waves, School of Information Science and Engineering, Southeast University, Nanjing 210096, China.

This paper presents a D-band dual linear-polarized wideband high-gain reflectarray (RA) antenna using low-temperature co-fired-ceramic (LTCC) technology. The proposed element comprises a dual-polarized magnetoelectric (ME) dipole and a multilayer slot-coupling substrate-integrated waveguide (SIW) phase-delay structure, which are organized in accordance with the receiving/reradiating (R/R) principle. The coverage of phase shifts for both orthogonal polarizations is set to be greater than 360 degrees by varying the length of the phase-delay structure.

View Article and Find Full Text PDF

In Silico Design of Dual Estrogen Receptor and Hsp90 Inhibitors for ER-Positive Breast Cancer Through a Mixed Ligand/Structure-Based Approach.

Molecules

December 2024

Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche "STEBICEF", University of Palermo, Viale delle Scienze, Ed. 17, 90128 Palermo, Italy.

Breast cancer remains one of the most prevalent and lethal malignancies in women, particularly the estrogen receptor-positive (ER+) subtype, which accounts for approximately 70% of cases. Traditional endocrine therapies, including aromatase inhibitors, selective estrogen receptor degraders/antagonists (SERDs), and selective estrogen receptor modulators (SERMs), have improved outcomes for metastatic ER+ breast cancer. However, resistance to these agents presents a significant challenge.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!